Onc Now: Episode 19: Part 2 – Key Insights from SGO 2025 - European Medical Journal

Onc Now: Episode 19: Part 2 – Key Insights from SGO 2025

Oncology

Onc Now | Episode 19

In the second part of this special episode of Onc Now, Jonathan Sackier continues his thrilling conversation with Bradley Monk, a leading gynaecologic oncologist, with an in-depth discussion of the DUO-E trial, Monk’s most impactful Society of Gynecologic Oncology (SGO) insights, and the integration of AI into the clinic.

Apple | Spotify | Amazon Music | Youtube | Download MP3 (27 mins)

Bradley Monk

 

Bradley Monk is a leading gynaecologic oncologist and Medical Director of Late-Phase Clinical Research at Florida Cancer Specialists. With over 30 years of experience, he has held major academic roles at UC Irvine and Creighton University Monk has led pivotal trials in ovarian and cervical cancer, contributing to the global approval of numerous therapies. He is internationally recognised for his leadership in gynaecologic cancer research and clinical innovation. 

Timestamps: 

00:00 Introduction 

00:40 – Quickfire questions 

06:19 – Inspiration 

08:31 – Molecular basis of cancer treatment 

12:12 – DUO-E trial design 

14:12 – Barriers to 4-drug regimen approval and access 

20:01 – Most impactful SGO insights 

21:10 – AI integration 

24:03 – Three wishes 

26:30 Outro 

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.